The goal of the ovarian research program is to develop a strategy to accurately identify ovarian cancers that would otherwise be lethal at a stage when they are readily curable.

If ovarian cancer is caught early, the five-year survival rate for ovarian cancer patients is greater than 90 percent, yet less than 25 percent are found this early.

The Canary ovarian cancer team was formed in 2005 in response to the need for tools to detect lethal types of ovarian cancer at an early stage, with the highest curability. Since that time, the team has completed collaborative projects in biomarker discovery, validation, molecular imaging, and screening modeling, and the group has moved blood and imaging tests into clinical trials. The team has also served as a model for collaborative teamwork in the field of early detection.

Learn more about the Canary Ovarian Cancer Program

Ovarian Program Infographic

Download our infographic to view Canary’s progress in the field of ovarian cancer early detection. It’s a great piece to share with people in your network to encourage them to donate to your Canary Challenge fundraising efforts.

Dr. McIntosh is involved in tumor immunology: using the body’s own immune response to detect forming tumors by imaging or blood biomarkers.